PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease (CAD), today announced that it has secured $8 million USD equity financing, led...
From PlaqueTecMay 2 2024 PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease , today announced that it has secured $8 million USD equity financing, led by Lord Moynihan of Chelsea alongside the Future Fund, with support from existing investors.
BIOCARTA is a bioinformatics discovery platform that interrogates data and groups patients with CAD into endotypes with defined signatures of the disease. BIOCARTA correlates in vivo biomarkers localising at the disease site with plaque imaging, genomic analysis, blood biochemistry and clinical and demographic phenotypes to further enhance a unique understanding of disease.
At the heart of BIOCARTA is PlaqueTec’s BIOPATTERN trial, which uses the Company’s proprietary blood sampling device, the Liquid Biopsy System™, to collect samples containing biomolecules localising at or being released by coronary plaque. This equity financing will support the ongoing trial, enabling the collection of new data to expand BIOCARTA and generate novel site-of-disease insights that will accelerate a precision medicine approach to improve treatment outcomes for patients with CAD.
CAD is a leading cause of death worldwide and represents an area with significant unmet medical need. The continued support from our existing investors and additional funding from the Future Fund reinforces the potential of our technology and BIOCARTA database, and brings us closer to achieving our vision of opening a new frontier of precision medicine for millions of patients with CAD worldwide.
Coronary Artery Disease Medicine Precision Medicine
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
CN Bio raises $21 million USD in first close of Series B investment roundBayland Capital and founding shareholder, CN Innovations Holdings Ltd, to invest $10 M and $5.5 M, respectively. Investment will expand product development and scaling of the organization to meet increased demand for Organ-on-a-Chip (OOC) solutions.
Read more »
Busy section of Glasgow's M8 set to close from today for two weeksA busy part of Glasgow's M8 is set to close from today for two weeks for 'essential' road works. Repairs will take place from 8pm - 6pm on the M8 eastbound at the Junction 15 off-slip to the city's Castle Street.
Read more »
Dan Ashworth move to Man United ‘close’ as new details emerge todayThe inside track on the football stories that matter
Read more »
Daily horoscope May 2, 2024: Today's predictions for your star signAs Pluto goes into reverse, friendships may be tested.
Read more »
Horoscope today, May 2, 2024: Daily star sign guide from Mystic Meg...Exploring the Dark Side of the Zodiac: Worst Traits of Each Star Sign
Read more »
No7 cream that combines 3 top skincare ingredients reduced from £40 to £10 todayFor one day only Boots shoppers can snap up the new No7 Pure Retinol, Vitamin C & SPF 30 Day Cream Duo for just instead of the usual £39.95. Here's how to access this deal...
Read more »